The 10 references in paper E. Krutikov S., V. Zhitova A., Е. Крутиков С., В. Житова А. (2016) “Эффективность метилэтилпиридинола при лечении нефропатии у больных с сахарным диабетом 1-го типа // The effectiveness of methylethylpiridinol in the treatment of nephropathy in patients with diabetes mellitus type I” / spz:neicon:nefr:y:2016:i:5:p:24-29

1
Oever IAM, Raterman HG, Nurmohamed MT et al. Endothelial Dysfunction, Inflammation, and Apoptosis in Diabetes Mellitus. Mediators of Inflammation 2010;ID 792393. doi:10.1155/2010/792393
(check this in PDF content)
2
Смирнов АВ, Добронравов ВА, Кисина АА и др. Клинические рекомендации по диагностике и лечению диабетической нефропатии. Нефрология 2015; 19(1): 67-77 [Smirnov AV, Dobronravov VA, Kisina AA i dr. Clinicheskie rekomendatcii po diagnostike i lecheniiu diabeticheskoi` nefropatii. Nefrologiia 2015; 19(1): 67-77].
(check this in PDF content)
3
Бобкова ИН, Шестакова МВ, Щукина АА. Диабетическая нефропатия – фокус на повреждение подоцитов. Нефрология 2015;19(2):33-44 [Bobkova IN, Shestakova MV, Shchukina AA. Diabeticheskaia nefropatiia – fokus na povrezhdenie podotcitov. Nefrologiia 2015;19(2):33-44].
(check this in PDF content)
4
Ozougwu JC, Obimba KC, Belonwu CD, Unakalamba CB. The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. J Physiol Pathophysiol 2013; 4(4):46–57. doi:10.5897/JPAP2013.0001
(check this in PDF content)
5
Kyrgios I, Maggana I, Giza S et al. Suboptimal glycaemic control enhances the risk of impaired prothrombotic state in youths with type 1 diabetes mellitus. Diabetes & Vascular Disease Research 2014;11(3):208–216
(check this in PDF content)
6
Nazratuna N, Mahmooda AA, Kuppusamya UR et al. Diabetes mellitus exacerbates advanced glycation end product accumulation in the veins of end-stage renal failure patients. Vascular Medicine 2006;11:245–250
(check this in PDF content)
7
Ferreiro JL, Gómez-Hospital JA, Dominick J. Angiolillo Platelet abnormalities in diabetes mellitus. Diabetes & Vascular Disease Research 2010;7(4):251–259. doi:10.1177/1479164110383994
(check this in PDF content)
8
Hall HM, Banerjee S, McGuire DK. Variability of clopidogrel response in patients with type 2 diabetes mellitus. Diabetes & Vascular Disease Research 2011;8(4):245–253
(check this in PDF content)
9
Бондаренко ИЗ, Ширшина ИА. Механизмы тромбообразования, ассоциированные с сахарным диабетом: что определяет прогноз интервенционного вмешательства? Сахарный диабет 2013; (3):58–63. doi:http://dx.doi. org/10.14341/2072-0351-95 [Bondarenko IZ, Shirshina IA. Mehanizmy` tromboobrazovaniia, assotciirovanny`e s saharny`m diabetom: chto opredeliaet prognoz interventcionnogo vmeshatel`stva? Saharny`i` diabet. 2013;(3):58–63. doi:http:// dx.doi.org/10.14341/2072-0351-95]
(check this in PDF content)
10
Randriamboavonjy V, Fleming I. Insulin, insulin resistance, and platelet signaling in diabetes. Diabetes Care 2009;32(4):528– 530. doi:http://dx.doi.org/10.2337/dc08-1942 Сведения об авторах: Проф. Крутиков Евгений Сергеевич
(check this in PDF content)